The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.. Growth in the market can primarily be attributed to factors such as demand for pre-packed disposable columns, increasing demand for therapeutic antibodies, and increasing pharmaceutical R&D spending
The agarose-based protein A segment to hold the largest market share in 2020. Based on product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. . In 2020, the agarose-based protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the agarose being the most widely used matrix resin for the attachment of ligands that bind proteins.
The recombinant protein A segment to hold the largest market share in 2020. Based on type, the protein A resin market is segmented into recombinant protein A and natural protein.In 2020, the recombinant protein A segment is expected to command the largest share of the protein A resin market.
The large share of this segment can be attributedto the frequent use of recombinant protein A resins during the production of monoclonal antibodies.
The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020. Based on end user, the protein A resin market is segmented into pharmaceutical & biopharmaceutical companies, academic research institutes, and other end users.In 2020, the pharmaceutical and biopharmaceutical companiessegment is expected to command the largest share of the protein A resin market.
The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.
The Asia Pacific region to witness the highest growth during the forecast period. Geographically, North America dominated the global protein A resin market in 2020.However, the Asia Pacific market is expected to register the highest during the forecast period.
The major factors driving the growth of the Asia Pacific market include increased R&D activities, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub.Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centers in the region.
Also, local major players such as Ranbaxy, Dr. Reddy’s, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.
Break of primary participants was as mentioned below: • By Company Type: Tier I: 40%, Tier II: 30%, Tier III: 30% • By Designation:C-Level Executives: 27%, Directors:18%, Others: 55% • By Region:North America: 40%, Europe: 20%, Asia Pacific : 30%, Latin America: 8%, Middle-East: 2%
GE Healthcare(US), Repligen Corporation (US), and Merck Millipore (Germany)were the leading players in the protein A resin market.
Research Coverage This report studies the protein A resin market based on product,type, application, end-user, and region.The report also studies the different factors (such as drivers, restraints,challenges, and opportunities) affecting the market growth.
It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the protein A resinmarket, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the protein A resin market and garner greater market shares.
Our reports have been used by over 10K customers, including:
The APS software market was valued at US$ 1,491.22 million in 2020 and is projected to reach US$ 2,941.27 million by 2028; it is expected to grow at a CAGR of 9.0% from 2021 to 2028. The global APS software market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South...
The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19...
The nucleotides market is expected to grow at a CAGR of over 8% during the forecast period. The major factor driving the market studied is the growing demand for nucleotides from pharmaceuticals and Increased Demand due to the COVID-19 Outbreak. On the flip side, the high manufacturing cost of nucleotides are hindering the growth of the market. -...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
The mass spectrometry market size is expected to grow from an estimated USD 4.1 billion in 2020 to USD 5.6 billion by 2025, at a CAGR of 6.5%. Increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and growing...
The chromatography resin market size is estimated to be USD 2.2 billion in 2020 and is projected to reach USD 3.3 billion by 2025, at a CAGR of 8.2% between 2020 and 2025. Factors such as increasing demand for therapeutic antibodies, public-private investment in pharmaceutical & life science research, and rising concern for food safety will...
The global flow imaging microscopy market size is projected to reach USD 45 million by 2025 from USD 32 million in 2020, at a CAGR of 7.4%. The growth of the market is attributed to increasing investment in the field of nanotechnology, growing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across...
75 pages •
By Asia Market Information & Development Company
• Jan 2021
This study focuses on China’s Dimethylformamide industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...
The global pharmaceutical contract development and manufacturing market is projected to reach USD 146.1 billion by 2025 from USD 100.7 billion in 2020, at a CAGR of 7.7% during the forecast period. Market growth is driven mainly by factors such as rising demand for generics, increasing investments in pharmaceutical R&D, and investments in...
The market of Humic Acid is projected to grow at a CAGR of over 4% during the forecast period. The drivers of the market are its growing application in agriculture sector, and increasing usage in making animal feed. Various chemical counterparts and unfavorable conditions arising due to the COVID-19 outbreak are the restraints that hinder...
Gross Domestic Product
Animal Feed Production
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.